X0306 4 2019-11-26 0 0001793294 PPD, Inc. PPD 0001801814 Fikry Christopher C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 See Remarks Non-voting common stock 2020-02-10 4 D 0 6645 D 0 D Common stock 2020-02-10 4 A 0 6645 A 6645 D Common stock 2020-02-10 4 P 0 7400 27.00 A 14045 D Stock Options (Right to Buy) 21.70 2019-11-26 4 A 0 40093 0.00 A 2029-11-26 Non-voting common stock 40093 40093 D Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis. Shares were acquired in a directed share program in connection with the Issuer's initial public offering. Represents stock options previously granted to the reporting person on November 26, 2019. These stock options were already reflected on the reporting person's previously filed Form 3. Represents 29,032 stock options which are unvested and will vest in equal annual installments on November 26, 2020, November 26, 2021, November 26, 2022, November 26, 2023 and November 26, 2024 and 11,061 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 29,032 stock options with an exercise price of $21.70 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2020-2024. Title: EVP, Global Laboratory Services /s/ B. Judd Hartman, as Attorney-in-Fact 2020-02-12